cyclohexanol has been researched along with topiramate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A | 1 |
| Alexandre, J; Durand, JP; Goldwasser, F; Guillevin, L | 1 |
| Peres, MF; Vieira, DS | 1 |
| Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I | 1 |
| Barceló, B; Castanyer, B; Puiguriguer, J; Yates, C | 1 |
| Crystal, SC; Grosberg, BM; Hutchinson, S; Robbins, MS | 1 |
| Almela, P; Aracil-Fernández, A; Manzanares, J | 1 |
| Cooper-Kazaz, R | 1 |
8 other study(ies) available for cyclohexanol and topiramate
| Article | Year |
|---|---|
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride | 2001 |
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyclohexanols; Female; Fructose; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nervous System Diseases; Recovery of Function; Topiramate; Venlafaxine Hydrochloride | 2005 |
Tension-type headache with aura.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Bromazepam; Cyclohexanols; Fructose; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Topiramate; Venlafaxine Hydrochloride; Vision Disorders | 2006 |
Topiramate use in alprazolam addiction.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Fructose; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Topiramate; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
[Delayed seizures after topiramate, venlafaxine and quetiapine overdose].
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Overdose; Fatal Outcome; Female; Fructose; Humans; Quetiapine Fumarate; Seizures; Time Factors; Topiramate; Venlafaxine Hydrochloride; Young Adult | 2010 |
Teaching case: menopausal migraine.
Topics: Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Herbal Medicine; Hot Flashes; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Migraine Disorders; Postmenopause; Topiramate; Venlafaxine Hydrochloride | 2010 |
Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.
Topics: Analysis of Variance; Animals; Anticonvulsants; Anxiety; Behavior, Animal; Body Temperature; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Tolerance; Fructose; gamma-Aminobutyric Acid; Male; Marijuana Abuse; Mice; Models, Animal; Motor Activity; Nucleus Accumbens; Pregabalin; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Topiramate; Transcription, Genetic; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2013 |
Treatment of night eating syndrome with topiramate: dawn of a new day.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Circadian Rhythm; Cyclohexanols; Drug Therapy, Combination; Feeding and Eating Disorders; Feeding Behavior; Female; Fructose; Humans; Middle Aged; Sleep Initiation and Maintenance Disorders; Topiramate; Venlafaxine Hydrochloride | 2012 |